Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems

Fucoidan is a heterogeneous group of polysaccharides isolated from marine organisms, including brown algae and marine invertebrates. The physicochemical characteristics and potential bioactivities of fucoidan have attracted substantial interest in pharmaceutical industries in the past few decades. These polysaccharides are characterized by possessing sulfate ester groups that impart negatively charged surfaces, low/high molecular weight, and water solubility. In addition, various promising bioactivities have been reported, such as antitumor, immunomodulatory, and antiviral effects. Hence, the formulation of fucoidan has been investigated in the past few years in diverse pharmaceutical dosage forms to be able to reach their site of action effectively. Moreover, they can act as carriers for various drugs in value-added drug delivery systems. The current work highlights the attractive biopharmaceutical properties of fucoidan being formulated in oral, inhalable, topical, injectable, and other advanced formulations treating life-quality-affecting diseases. Therefore, the present work points out the current status of fucoidan pharmaceutical formulations for future research transferring their application from in vitro and in vivo studies to clinical application and market availability.

1. Introduction

Fucoidan encompasses a heterogenous class of polysaccharides found in the extracellular matrix and cell wall of brown seaweeds (Phaeophyta) and marine invertebrates with potential physiological functions. It acts as cellulose and hemicellulose cross-linkers, playing a crucial role in cell wall integrity, in addition to preventing algae dryness during summer and low tide periods, among others [1,2]. Chemically, fucoidan is composed of a sulfated backbone of diverse sugar monomers, mainly L-fucose, as well as galactose, glucose, xylose, mannose, and uronic acids. However, some proteins and minerals such as calcium, magnesium, manganese, copper, potassium, selenium, sodium, and zinc can be also found [3]. The heterogeneity in fucoidan’s chemical composition regarding monomeric composition, glycosidic linkages, sulfation pattern and content, presence of other constituents, and molecular weight has been investigated extensively in the past few years.
These variations are mostly associated with different factors, including algae species, season of harvesting, extraction processes, geographical origin, and vegetative phase [4,5,6,7]. The diversity in fucoidan’s biochemical composition has enriched various scientific fields with investigations of potential bioactivities and applications. For instance, fucoidan either with low, intermediate, or high molecular weight has gained much interest recently due to its promising biological and pharmacological properties such as heparin-like anticoagulant, antitumor, anti-angiogenic, anti-inflammatory, anti-hyperglycemic, antiviral, and immunomodulatory bioactivities [8,9,10,11]. As a result, fucoidan-containing products are consumed widely for nutraceutical and health-promoting benefits based on unique molecular mechanisms. Liu et al. reported that fucoidan can be beneficial as a nutraceutical product against obesity and abnormal lipid accumulation within cells through regulating cellular glucose consumption as it reduces glycerol-3-phosphate dehydrogenase (GPDH) functionality. Furthermore, high-molecular-weight fucoidan extracted from Fucus vesiculosus has also been found to have antioxidant, antihyperglycemic, anti-inflammatory, and anticoagulant effects which are attributed to multiple mechanisms, including the inhibition of dipeptidyl peptidase-IV enzyme as one of the possible mechanisms involved in the anti-hyperglycemic activity of fucoidan, and its selective inhibition of the cyclooxygenase-2 (COX-2) enzyme, responsible for its anti-inflammatory effect [12]. Other reported mechanisms include the role of fucoidan in modulating oxidative stress and gut microbiota [13,14].

 

Further investigations have confirmed this activity in perfluorooctanoic acid-associated obesity in an animal model [15]. These fucoidan products used the dried fucoidan extract derived from Undaria pinnatifida (a type of brown seaweed) for the preparation of functional foods in the form of cookies and noodles [16]. Edible films are another formulation technique for incorporating fucoidan into alginate-chitosan gel films as nutraceuticals with antioxidant and anti-inflammatory effects [17]. Other cosmeceutical applications (e.g., anti-photoaging and skin protective activity) were shown for fucoidan products against UVB irradiation via its antioxidant effect and its inhibition of oxidative stress markers and matrix metallopeptidase-9 (MMP-9) expressions [18].

 

Fucoidan also offers some attractive physical properties enabling its use in diverse pharmaceutical formulation techniques (Figure 1). These physical characteristics include, for instance, mucoadhesion, pH, temperature, and enzyme response. In addition, fucoidan has a strong ability to bind to numerous compounds and macromolecules. The binding affinity is mainly resulting from the negatively charged surface, the degree of sulfation, and molecular weight. Additionally, fucoidan has low apparent viscosity with a pseudoplastic flow, preventing its use as a gelling or thickening agent. On the other hand, upon mixing fucoidan with oppositely charged polymers, gel, matrices, and films can be formed. Moreover, fucoidan is known for its high stability under acidic and alkaline conditions [19].
In the past few decades, considerable progress has been achieved in designing suitable formulations of fucoidan as a therapeutic agent, polymeric drug carrier, excipient, and matrix-forming system. However, there is still a need for additional well-established clinical investigations to evaluate its safety and efficacy on humans.
To write down this review, we used the following keywords in our literature search: fucoidan formulations, drug delivery, fucoidan dosage forms, biological and pharmacological properties of fucoidan, scaling-up marine drugs, and advanced formulations. We included articles related to pharmaceutical formulation and pharmacological properties of fucoidan and excluded articles discussing marine drugs other than fucoidan. The PubMed database was used with a time frame of publications indexed at the time period between 2005 and 2022. The limitations of our review are reported pharmaceutical formulation of fucoidan, their possible dosage forms, advanced drug delivery systems, biological activity, and pharmaceutical applications. We highlight the latest advances in biomedical and pharmaceutical applications of fucoidan as a carrier for drug delivery and tissue engineering scaffolds or as a therapeutic agent on its own. Firstly, the established biopharmaceutical properties of fucoidan such as mucoadhesion, pH, thermal, and enzymatic response, as well as targeting ability, are discussed. Then, the possible dosage forms, routes of administration, and advanced formulation approaches are explained. Finally, the possibilities and challenges of scaling up fucoidan-based products are investigated.

Download the full review as PDF here: Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems

or read it here

Haggag, Y.A.; Abd Elrahman, A.A.; Ulber, R.; Zayed, A. Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems. Mar. Drugs 2023, 21, 112.
https://doi.org/10.3390/md21020112

 

You might also like